Resources
Latest articles.Sharp, plain-spoken analysis.
Analysis and perspective on direct-to-employer pharmacy programs, drug benefit integrity, and the structural changes reshaping pharmacy benefits.
How to Audit Your PBM: A Practical Action Guide for Self-Funded Employers
Most self-funded employers have never audited their PBM. Under ERISA and CAA 2026, that is a fiduciary risk. A step-by-step guide.
Read more →CAA 2026 and Pharmacy Benefits: What Self-Funded Employers Must Do Now
CAA 2026 created new PBM disclosure requirements, rebate pass-through mandates, and fiduciary obligations. What changed and what plan sponsors must do.
Read more →How to Evaluate PBM Fiduciary Alignment: A Practical Guide for Plan Sponsors
What genuine fiduciary alignment requires, how to evaluate your current PBM against that standard, and what to do when it falls short.
Read more →ERISA Fiduciary Duty and Pharmacy Benefits: What Every Self-Funded Employer Must Know in 2026
Plan fiduciaries face personal liability for pharmacy decisions. What the prudent expert standard requires and how to demonstrate compliance.
Read more →How to Evaluate a Direct-to-Employer Pharmacy Platform: Five Questions to Ask
Not all direct-to-employer platforms are equivalent. Five structural questions that separate real infrastructure from cash-pay workarounds.
Read more →What Benefits Consultants Need to Know About Manufacturer-Direct Pharmacy Programs
Manufacturer-direct pharmacy programs are reaching employer conversations fast. What the model requires and how to evaluate it for clients.
Read more →Manufacturer Direct vs. PBM for GLP-1s: What's the Actual Cost?
PBMs report low net GLP-1 costs. Manufacturers offer direct pricing. How to compare the two channels and what employers actually pay.
Read more →ERISA, CAA, and the Self-Funded Employer's Duty to Evaluate Direct Drug Channels
CAA 2026 raised the bar for pharmacy benefit oversight. Self-funded employers now face personal liability for decisions they cannot document.
Read more →How Manufacturers Can Launch a Direct-to-Employer Drug Program
Launching a manufacturer direct channel takes more than pricing. The operational infrastructure required to make DTE work inside a benefit.
Read more →What Is a Direct-to-Employer Pharmacy Benefit Program?
How self-funded employers access manufacturer-direct drug pricing inside the benefit, without routing around the PBM.
Read more →